Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: A pilot study in patients with refractory malignancies

Cancer

Volumn 94, Issue 9, 2002, Pages 2409-2415

  Pedrazzoli, Paolo ^a   Da Prada, Gian Antonio ^b   Giorgiani, Giovanna ^c   Schiavo, Roberta ^a   Zambelli, Alberto ^b   Giraldi, Eugenia ^c   Landonio, Giuseppe ^a   Locatelli, Franco ^c   Siena, Salvatore ^a   Della Cuna, Gioacchino Robustelli ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Allogeneic blood stem cell transplantation; Graft versus tumor disease; Performance status; Refractory malignancies

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HLA ANTIGEN; METHOTREXATE;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BLOOD TOXICITY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; KIDNEY CARCINOMA; MALE; MELANOMA; NEUTROPENIA; OVARY CARCINOMA; PRIORITY JOURNAL; SARCOMA; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; CHILD; CYCLOPHOSPHAMIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; SARCOMA; SURVIVAL RATE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIDARABINE;

EID: 0036569579     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10491     Document Type: Article

References (22)

1. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts
2. Graft-versus-leukemia reactions after bone marrow transplantation
3. Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: Results of a randomized trial
4. Allogeneic peripheralblood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer
5. Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer
6. Graft-versus-tumour effect in non-small-cell lung cancer after allogeneic peripheral blood stem cell transplantation
7. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model
8. Engraftment of allogeneic hematopoietic progenitor cells with purine analogue-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
9. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
10. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma
11. Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
12. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
13. Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects
14. Adoptive cellular immunotherapy of cancer in mice using allogeneic T-cells
15. Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma
16. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
17. Human cytomegalovirus infection in pediatric patients given allogeneic bone marrow transplantation: Role of early treatment of antigenemia on patients' outcome
18. Myeloid and lymphoid chimerism after T-cell depleted bone marrow transplantation: Evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA
19. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
20. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
21. Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma
22. The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukemia relapsing following allogeneic transplantation